skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Nome da Publicação: Neuro-Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
Material Type:
Artigo 		Adicionar ao Meu Espaço

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

Louis, David N ; Perry, Arie ; Wesseling, Pieter ; Brat, Daniel J ; Cree, Ian A ; Figarella-Branger, Dominique ; Hawkins, Cynthia ; Ng, H K ; Pfister, Stefan M ; Reifenberger, Guido ; Soffietti, Riccardo ; von Deimling, Andreas ; Ellison, David W

Neuro-oncology (Charlottesville, Va.), 2021-08, Vol.23 (8), p.1231-1251 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
2
EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma
EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma

Hübner, Jens-Martin ; Müller, Torsten ; Papageorgiou, Dimitris N ; Mauermann, Monika ; Krijgsveld, Jeroen ; Russell, Robert B ; Ellison, David W ; Pfister, Stefan M ; Pajtler, Kristian W ; Kool, Marcel

Neuro-oncology (Charlottesville, Va.), 2019-07, Vol.21 (7), p.878-889 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
3
Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2
Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2
Material Type:
Artigo 		Adicionar ao Meu Espaço

Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2

Anderton, Jennifer A ; Lindsey, Janet C ; Lusher, Meryl E ; Gilbertson, Richard J ; Bailey, Simon ; Ellison, David W ; Clifford, Steven C

Neuro-oncology (Charlottesville, Va.), 2008-12, Vol.10 (6), p.981-994 [Periódico revisado por pares]

England: Duke University Press

Texto completo disponível

Citações Citado por
4
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q

Baroni, Lorena V ; Sundaresan, Lakshmikirupa ; Heled, Ayala ; Coltin, Hallie ; Pajtler, Kristian W ; Lin, Tong ; Merchant, Thomas E ; McLendon, Roger ; Faria, Claudia ; Buntine, Molly ; White, Christine L ; Pfister, Stefan M ; Gilbert, Mark R ; Armstrong, Terri S ; Bouffet, Eric ; Kumar, Sachin ; Taylor, Michael D ; Aldape, Kenneth D ; Ellison, David W ; Gottardo, Nicholas G ; Kool, Marcel ; Korshunov, Andrey ; Hansford, Jordan R ; Ramaswamy, Vijay

Neuro-oncology (Charlottesville, Va.), 2021-08, Vol.23 (8), p.1360-1370 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
5
A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702)
A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702)

Stokland, Tore ; Liu, Jo-Fen ; Ironside, James W ; Ellison, David W ; Taylor, Roger ; Robinson, Kathryn J ; Picton, Susan V ; Walker, David A

Neuro-oncology (Charlottesville, Va.), 2010-12, Vol.12 (12), p.1257-1268 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
6
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial

Upadhyaya, Santhosh A ; Robinson, Giles W ; Onar-Thomas, Arzu ; Orr, Brent A ; Billups, Catherine A ; Bowers, Daniel C ; Bendel, Anne E ; Hassall, Tim ; Crawford, John R ; Partap, Sonia ; Fisher, Paul G ; Tatevossian, Ruth G ; Seah, Tiffany ; Qaddoumi, Ibrahim A ; Vinitsky, Anna ; Armstrong, Gregory T ; Sabin, Noah D ; Tinkle, Christopher L ; Klimo, Paul ; Indelicato, Danny J ; Boop, Frederick A ; Merchant, Thomas E ; Ellison, David W ; Gajjar, Amar

Neuro-oncology (Charlottesville, Va.), 2019-10, Vol.21 (10), p.1319-1330 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
7
Risk stratification in pediatric low-grade glioma and glioneuronal tumor treated with radiation therapy: an integrated clinicopathologic and molecular analysis
Risk stratification in pediatric low-grade glioma and glioneuronal tumor treated with radiation therapy: an integrated clinicopathologic and molecular analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Risk stratification in pediatric low-grade glioma and glioneuronal tumor treated with radiation therapy: an integrated clinicopathologic and molecular analysis

Acharya, Sahaja ; Liu, Jo-Fen ; Tatevossian, Ruth G ; Chiang, Jason ; Qaddoumi, Ibrahim ; Gajjar, Amar ; Walker, David ; Harreld, Julie H ; Merchant, Thomas E ; Ellison, David W

Neuro-oncology (Charlottesville, Va.), 2020-08, Vol.22 (8), p.1203-1213 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
8
SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study
SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study

Ritzmann, Timothy A ; Chapman, Rebecca J ; Kilday, John-Paul ; Thorp, Nicola ; Modena, Piergiorgio ; Dineen, Robert A ; Macarthur, Donald ; Mallucci, Conor ; Jaspan, Timothy ; Pajtler, Kristian W ; Giagnacovo, Marzia ; Jacques, Thomas S ; Paine, Simon M L ; Ellison, David W ; Bouffet, Eric ; Grundy, Richard G

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (6), p.936-948 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
9
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026)
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026)

Leary, Sarah E S ; Kilburn, Lindsay ; Geyer, J Russell ; Kocak, Mehmet ; Huang, Jie ; Smith, Kyle S ; Hadley, Jennifer ; Ermoian, Ralph ; MacDonald, Tobey J ; Goldman, Stewart ; Phillips, Peter ; Young Poussaint, Tina ; Olson, James M ; Ellison, David W ; Dunkel, Ira J ; Fouladi, Maryam ; Onar-Thomas, Arzu ; Northcott, Paul A

Neuro-oncology (Charlottesville, Va.), 2022-07, Vol.24 (7), p.1178-1190 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
10
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor

Upadhyaya, Santhosh A ; Campagne, Olivia ; Billups, Catherine A ; Orr, Brent A ; Onar-Thomas, Arzu ; Tatevossian, Ruth G ; Mostafavi, Roya ; Myers, Jason R ; Vinitsky, Anna ; Moreira, Daniel C ; Lindsay, Holly B ; Kilburn, Lindsay ; Baxter, Patricia ; Smith, Amy ; Crawford, John R ; Partap, Sonia ; Bendel, Anne E ; Aguilera, Dolly G ; Nichols, Kim E ; Rampersaud, Evadnie ; Ellison, David W ; Klimo, Paul ; Patay, Zoltan ; Robinson, Giles W ; Broniscer, Alberto ; Stewart, Clinton F ; Wetmore, Cynthia ; Gajjar, Amar

Neuro-oncology (Charlottesville, Va.), 2023-02, Vol.25 (2), p.386-397 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.